SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Geron Corp – ‘8-K’ for 6/5/20

On:  Tuesday, 6/9/20, at 5:28pm ET   ·   For:  6/5/20   ·   Accession #:  1206774-20-1800   ·   File #:  0-20859

Previous ‘8-K’:  ‘8-K’ on / for 5/28/20   ·   Next:  ‘8-K’ on / for 8/6/20   ·   Latest:  ‘8-K’ on 3/20/24 for 3/19/24   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/09/20  Geron Corp                        8-K:5,9     6/05/20    2:154K                                   DG3/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-10.1     2018 Equity Incentive Plan, as Amended              HTML    116K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 5, 2020

GERON CORPORATION
(Exact name of registrant as specified in its charter)

Delaware       0-20859       75-2287752
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

919 E. HILLSDALE BLVD., SUITE 250
FOSTER CITY, CALIFORNIA 94404
(Address of principal executive offices, including zip code)

(650) 473-7700
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value GERN The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02       Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 5, 2020, Geron Corporation (the “Company”) held its 2020 Annual Meeting of Stockholders in a virtual meeting format, pursuant to notice duly given (the “2020 Annual Meeting”). At the 2020 Annual Meeting, the Company’s stockholders approved an amendment to the Company’s 2018 Equity Incentive Plan (the “2018 Plan”) to increase the shares issuable thereunder by 5,700,000 shares of the Company’s common stock. The amendment to 2018 Plan was adopted by the Board of Directors of the Company (the “Board”) on February 12, 2020, subject to stockholder approval, and became effective on June 5, 2020.

The 2018 Plan was initially adopted by the Board in March 2018 and approved by the stockholders in May 2018. The terms of the 2018 Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, other stock awards, and performance awards that may be settled in cash, stock, or other property. Upon adoption, the 2018 Plan had an initial share reserve of 10,000,000 shares of common stock. The aggregate number of shares of the Company’s common stock issuable under the 2018 Plan also included, as of the effective date of the 2018 Plan: (i) 2,895,419 unallocated shares that were remaining available for the grant of awards under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) as of the effective date of the 2018 Plan; and (ii) certain Returning Shares granted under 2011 Plan, the Company’s 1992 Stock Option Plan, the Company’s 1996 Directors’ Stock Option Plan and the Company’s Amended and Restated 2002 Equity Incentive Plan (collectively, the “Prior Plans”) that may become available for grant under the 2018 Plan from time to time; and as of June 5, 2020 (iii) 5,700,000 additional shares approved by stockholders at the 2020 Annual Meeting. “Returning Shares” means shares subject to outstanding stock awards granted under the Prior Plans that, from and after the effective date of the 2018 Plan, (i) expire or terminate for any reason prior to exercise or settlement, (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii) other than with respect to outstanding stock options and stock appreciation rights granted under the Prior Plans with an exercise or strike price of at least 100% of the fair market value of the underlying Company common stock on the date of grant, are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a stock award. Eligible participants under the 2018 Plan include the Company’s employees, consultants and directors, including the Company’s executive officers.

A more detailed summary of the material features of the 2018 Plan, including the terms of stock option grants thereunder, is set forth in the Company’s definitive proxy statement for the 2020 Annual Meeting filed with the Securities and Exchange Commission on April 14, 2020 (the “Proxy Statement”). That summary and the foregoing description are qualified in their entirety by reference to the text of the 2018 Plan, a copy of which is incorporated by reference as Exhibit 10.1 hereto.

Item 5.07       Submission of Matters to a Vote of Security Holders.

Only stockholders of record as of the close of business on April 9, 2020, the record date for the 2020 Annual Meeting, were entitled to vote at the 2020 Annual Meeting. As of April 9, 2020, 200,361,848 shares of common stock of the Company were outstanding and entitled to vote at the 2020 Annual Meeting, of which 140,578,647 shares of common stock of the Company were represented, in person or by proxy, constituting a quorum. The final results of the stockholder vote on each proposal brought before the 2020 Annual Meeting are as follows:

(a) Proposal 1. Each of the three (3) nominees to hold office as Class III members of the Board of Directors to serve for a three-year term expiring at the Company’s 2023 annual meeting of stockholders was elected based upon the following votes:

Name of Director Nominee Votes In Favor Votes Withheld Broker Non-Votes
Karin Eastham 40,343,908 5,815,482 94,419,257
V. Bryan Lawlis 42,920,447 3,238,943 94,419,257
Susan M. Molineaux 36,098,141 10,061,249 94,419,257

1


(b) Proposal 2. The amendment to the Company’s 2018 Equity Incentive Plan to increase the total shares issuable thereunder by 5,700,000 shares of common stock hereby was approved based upon the following votes:

Votes For       Votes Against       Abstentions       Broker Non-Votes
33,708,544   11,891,639   559,207   94,419,257

(c) Proposal 3. The non-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement was approved based upon the following votes:

Votes For       Votes Against       Abstentions       Broker Non-Votes
36,632,914   8,541,545   984,931   94,419,257

(d) Proposal 4. The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020 was ratified based upon the following votes:

Votes For       Votes Against       Abstentions       Broker Non-Votes
133,353,121   4,540,197   2,685,329   N/A

Item 9.01       Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.       Description
10.1 2018 Equity Incentive Plan, as amended

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

      GERON CORPORATION
     
Date: June 9, 2020 By: /s/ Stephen N. Rosenfield            
Name: Stephen N. Rosenfield
Title: Executive Vice President,
Chief Legal Officer and
Corporate Secretary

3



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
12/31/20
Filed on:6/9/20
For Period end:6/5/20DEF 14A
4/14/20DEF 14A,  DEFA14A
4/9/20
2/12/204
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/22  Geron Corp.                       424B5                  1:909K                                   ActiveDisclosure/FA
 3/29/22  Geron Corp.                       424B5                  1:910K                                   ActiveDisclosure/FA
 3/11/21  Geron Corp.                       10-K       12/31/20   83:12M                                    ActiveDisclosure/FA
11/06/20  Geron Corp.                       424B5                  1:101K                                   DG3/FA
11/05/20  Geron Corp.                       10-Q        9/30/20   53:8.9M                                   ActiveDisclosure/FA
 9/04/20  Geron Corp.                       S-3                    7:965K                                   DG3/FA
 8/06/20  Geron Corp.                       10-Q        6/30/20   48:7.4M                                   ActiveDisclosure/FA
Top
Filing Submission 0001206774-20-001800   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 3:11:44.3pm ET